Skip to main content


Latest articles

13-03-2019 | Diabetes | News | Article

Tailored CBT reduces depression, distress in type 2 diabetes

A patient-specific cognitive behavioral therapy and lifestyle counseling intervention can significantly improve psychological outcomes in type 2 diabetes patients with depression and/or regimen-related distress, say researchers.

12-03-2019 | Diabetes | News | Article

Adding second diabetes medication better than switching in face of poor response

Adding an additional glucose-lowering medication is better than switching to a different one in people with type 2 diabetes, even if the original seemed to have little or no effect, shows an analysis from the MASTERMIND consortium.

12-03-2019 | Diabetes | News | Article

Nurse-led intervention can reduce mortality risk after severe hypoglycemia

Assigning people with type 2 diabetes to 3 months of focused care with a specialist diabetes nurse after an episode of severe hypoglycemia reduces their risk for mortality over the following few years, research shows.

11-03-2019 | Diabetes | News | Article

Autoantibodies in pregnancy signal high risk for impending type 1 diabetes

Women with gestational diabetes who also have autoantibodies are highly likely to go on and develop type 1 diabetes, research shows.

11-03-2019 | Diabetes | News | Article

Modifiable cardiometabolic risk factors dominant type 1 diabetes mortality risk

The strongest predictors for mortality and cardiovascular disease disease in patients with type 1 diabetes are generally modifiable cardiometabolic risk factors, researchers report.

08-03-2019 | Diabetes | News | Article

CONCEPTT data show substantial cost savings with CGM in pregnancy

Using continuous glucose monitoring for all women with type 1 diabetes during pregnancy could save the UK National Health Service over 9 million pounds per year, report the CONCEPTT investigators.

08-03-2019 | Diabetes | News | Article

Similar weight-loss outcomes with one anastomosis, Roux-en-Y gastric bypass procedures

Findings from the YOMEGA trial indicate that the one anastomosis gastric bypass procedure is noninferior to standard Roux-en-Y gastric bypass in terms of weight loss and metabolic outcomes.

08-03-2019 | Diabetes | News | Article

TrialNet monitoring study shows risk-reducing effect of type 1 diabetes screening

Data from the TrialNet Pathway to Prevention study shows that monitoring high-risk relatives of people with type 1 diabetes markedly reduces the risk for those who develop the condition presenting with diabetic ketoacidosis.

08-03-2019 | Diabetes | News | Article

The DiRECT trial in practice

Following the positive 2-year results of DiRECT, this symposium shared the first-hand experiences of a dietician, a general practitioner, and a person with diabetes who participated in the DiRECT study.

07-03-2019 | Diabetes | News | Article

Double-checking C-peptide well after type 1 diagnosis can lead to reclassifications

Measuring C-peptide in everyone a minimum of 3 years after a clinical diagnosis of type 1 diabetes can result in some people being reclassified with other forms of diabetes, researchers report.

07-03-2019 | Diabetes | News | Article

UK diabetes prevention update underscores importance of program retention

The latest update from the UK’s National Health Service Diabetes Prevention Programme shows that persistence pays, and reveals weight loss and a reduction in glycated hemoglobin levels for people who have so far completed the intervention.

06-03-2019 | Diabetes | News | Article

Diabetes remission durable for a third of DiRECT participants

Just over a third of people who undertook a period on a very-low-calorie diet in the DiRECT trial to tackle type 2 diabetes are in remission 24 months later, the investigators have reported.

05-03-2019 | Diabetes | News | Article

Behavioral intervention has durable physical activity effect in type 2 diabetes

A behavioral intervention has lasting effects on physical activity levels, fitness, and vascular risk in people with type 2 diabetes, show the 3-year results of the randomized Italian Diabetes and Exercise Study 2.

05-03-2019 | Diabetes | News | Article

SUSTAIN 9 supports semaglutide, SGLT2 inhibitor combination

Adding the glucagon-like peptide-1 analog semaglutide to an existing sodium-glucose cotransporter 2 inhibitor improves glycemic control and bodyweight in patients with poorly controlled type 2 diabetes, SUSTAIN 9 data show.

04-03-2019 | Diabetes | News | Article

Meta-analysis confirms SGLT2 inhibitor heart failure, kidney disease benefits

Sodium-glucose cotransporter-2 inhibitors have a greater effect than glucagon-like peptide-1 receptor agonists on reducing hospitalization for heart failure and kidney disease progression in patients with type 2 diabetes, according to the findings of a systematic review and meta-analysis.

28-02-2019 | Diabetes | News | Article

Real-world HbA1c targets usually individualized, rarely achieved

Real-world data show that people with type 2 diabetes struggle to attain their glycated hemoglobin targets, despite these commonly being individualized.

28-02-2019 | Diabetes | News | Article

Engagement with mobile health intervention linked to improved glycemic control

Responsiveness to text message reminders about blood glucose monitoring is associated with glycemic benefit among adolescents with type 1 diabetes, study findings indicate.

27-02-2019 | Diabetes | News | Article

Empagliflozin benefits shown in African Americans

Empagliflozin significantly reduces glycated hemoglobin, blood pressure, and bodyweight versus placebo in African–American patients with type 2 diabetes and hypertension, phase III trial data show.

27-02-2019 | Diabetes | News | Article

Clinical variables boost predictive accuracy of prediabetes definitions

Agreement between five currently recommended definitions of intermediate hyperglycemia, or prediabetes, is poor, and their sensitivity for predicting type 2 diabetes is low, study findings indicate.

26-02-2019 | Diabetes | News | Article

CGM at diabetes diagnosis improves family psychosocial outcomes

Giving children continuous glucose monitoring from the point of diabetes diagnosis gives their caregivers greater confidence to manage hypoglycemia and reduces their diabetes-related distress, shows a randomized trial.